Skip to Main Content

Paper Details

High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer.
Brachytherapy
16
2017
Author NameAffiliation
David Jeffrey DemanesUniversity of California los angeles
Darlene VeruttipongUniversity of California los angeles
Michael L SteinbergUniversity of California los angeles
Mitchell KamravaUniversity of California los angeles
  • 1 - 4

Datasets

Release 1.2